NCT00457574View on ClinicalTrials.gov

Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

August 31, 2010

Conditions
Solid Tumors and Lymphomas
Interventions
DRUG

GMX1777

Sponsors

Lead Sponsor

Gemin X
All Listed Sponsors
lead

Gemin X

INDUSTRY

NCT00457574 - Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas | Biotech Hunter | Biotech Hunter